Investigation summary: based on the information available, the cause that contributed to the reported hematoma, edema, blood loss, and infection could not be established as the product was not available for analysis.Device history record review (dhr): the device history record review (dhr) confirmed that the device met all material, assembly and performance specifications.A risk review confirmed that the event is accounted for in the risk documentation.Device technical analysis: the device was not available for analysis; therefore, no physical or visual analysis of the product could be performed.The reported allegation of infection cannot be confirmed.Labeling review: a review of the device instructions for use (ifu) was completed and according to the ams700 instructions for use, hematoma, edema, blood loss, and infection are documented as adverse events.Investigation conclusion: based on this investigation a clear probable cause for the event cannot be established.Risk review and labeling review identified that the adverse events of hematoma, edema, infection and blood loss are known risks of the device.The cause of the hematoma, edema, infection and blood loss were not established by physician, although hematoma, edema, infection and blood loss are included in the labelling documentation for ipp device as an adverse event of implant surgical procedure of device and also the risks, benefits, and potential adverse events of all available treatment options should be discussed with the patient and considered by the physician and patient when choosing a treatment option is included in the document, therefore a conclusion code of known inherent risk of device was chosen.
|